Click image to enlargeUSF is conducting a clinical trial investigating the efficacy and safety of cariprazine compared with placebo in prevention of relapse in patients with Bipolar I disorder.
To be eligible for this 60 week patients must:
- Be 18 to 65 years of age and in general good health
- Have a diagnosis of Bipolar I disorder - current episode manic or depressive, with or without mixed features